Metraipolis › archive › dc_cd958e518982
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting — Europe PMC PMID:42279326
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42279326
- DOI
- 10.3390/cancers18111743
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:46:50.256Z
- SHA-256 of the archived text
18c83afb32744b77e6ce35e636c6e23ed994200b3c56d9bed084f7982ef4764a- Stable URL of this page
https://metraipolis.com/documento/dc_cd958e518982
How to cite
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting — Europe PMC PMID:42279326 — Europe PMC (en), https://europepmc.org/article/MED/42279326 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd958e518982 (Metraipolis archive dc_cd958e518982, sha256 18c83afb32744b77e6ce35e636c6e23ed994200b3c56d9bed084f7982ef4764a)
BibTeX
@misc{dccd958e518982,
title = {CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting — Europe PMC PMID:42279326},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42279326},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd958e518982; sha256 18c83afb32744b77e6ce35e636c6e23ed994200b3c56d9bed084f7982ef4764a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279326. Agents can read the archived copy with the MCP tool read_document.